key: cord-0290131-5qskzvjx
authors: Wieder, Cecilia; Lai, Rachel PJ; Ebbels, Timothy
title: Single sample pathway analysis in metabolomics: performance evaluation and application
date: 2022-04-12
journal: bioRxiv
DOI: 10.1101/2022.04.11.487976
sha: e8f13144e7e016b7ca7297c8e493289c47a67290
doc_id: 290131
cord_uid: 5qskzvjx

Single sample pathway analysis (ssPA) transforms molecular level omics data to the pathway level, enabling the discovery of patient-specific pathway signatures. Compared to conventional pathway analysis, ssPA overcomes the limitations by enabling multi-group comparisons, alongside facilitating numerous downstream analyses such as pathway-based machine learning. While in transcriptomics ssPA is a widely used technique, there is little literature evaluating its suitability for metabolomics. Here we provide a thorough benchmark of established ssPA methods (ssGSEA, GSVA, SVD (PLAGE), and z-score) using semi-synthetic metabolomics data, alongside the evaluation of two novel methods we propose: ssClustPA and kPCA. While GSEA-based and z-score methods outperformed the others in terms of recall, clustering/dimensionality reduction-based methods provided higher precision at moderate-to-high effect sizes. A case study applying ssPA to inflammatory bowel disease demonstrates how these methods yield a much richer depth of interpretation than conventional approaches, for example by clustering pathway scores to visualise a pathway-based patient subtype-specific correlation network. We also developed the sspa python package (freely available at https://pypi.org/project/sspa/), providing implementations of all the methods benchmarked in this study. This work underscores the value ssPA methods can add to metabolomic studies and provides a useful reference for those wishing to apply ssPA methods to metabolomics data. Author summary Pathway analysis is a computational method used to draw insights from omics data by identifying groups of molecules (biological pathways) which are important in a study. Single-sample pathway analysis is based on the same principles as conventional pathway analysis but allows researchers to compute the enrichment of pathways at an individual-sample level. This enables pathway-based patient stratification and facilitates a multitude of downstream analyses based on pathways, such as machine learning, or pathway-based visualization which would not be possible using conventional approaches. In this work we investigated the application of single-sample pathway analysis to metabolomics data, a field in which it has not been widely used to date. We first evaluated the most popular methods for single-sample pathway analysis using simulated metabolomics data, as well as two novel methods we developed. Following these tests, we used metabolomics data from inflammatory bowel disease patients to demonstrate how single-sample pathway analysis methods can be used to infer novel pathway-based insights with the advantage of discriminating between disease subtypes. Overall, our analysis provides readers with information on the performance of single-sample pathway analysis methods, whilst highlighting the potential of such methods in metabolomics research.

we propose: ssClustPA and kPCA. While GSEA-based and z-score methods outperformed the others in 17 terms of recall, clustering/dimensionality reduction-based methods provided higher precision at 18 moderate-to-high effect sizes. A case study applying ssPA to inflammatory bowel disease demonstrates 19 how these methods yield a much richer depth of interpretation than conventional approaches, for 20 example by clustering pathway scores to visualise a pathway-based patient subtype-specific 21 correlation network. We also developed the sspa python package (freely available at 22 https://pypi.org/project/sspa/), providing implementations of all the methods benchmarked in this 23 study. This work underscores the value ssPA methods can add to metabolomic studies and provides a 24 useful reference for those wishing to apply ssPA methods to metabolomics data.

Author summary 26 Pathway analysis is a computational method used to draw insights from omics data by identifying 27 groups of molecules (biological pathways) which are important in a study. Single-sample pathway 28 analysis is based on the same principles as conventional pathway analysis but allows researchers to 29 compute the enrichment of pathways at an individual-sample level. This enables pathway-based 30 patient stratification and facilitates a multitude of downstream analyses based on pathways, such as 31 machine learning, or pathway-based visualization which would not be possible using conventional 32 approaches. In this work we investigated the application of single-sample pathway analysis to 33 metabolomics data, a field in which it has not been widely used to date. We first evaluated the most 34 popular methods for single-sample pathway analysis using simulated metabolomics data, as well as 35 two novel methods we developed. Following these tests, we used metabolomics data from 36 inflammatory bowel disease patients to demonstrate how single-sample pathway analysis methods 37 can be used to infer novel pathway-based insights with the advantage of discriminating between Introduction 42 As metabolomics continues to gain traction in various fields of research, 43 interpretation of the results of such studies remains of paramount importance. This 44 is particularly key in untargeted experiments, in which as many compounds as 45 possible are assayed in order to build a comprehensive metabolic profile of the 46 phenotype under study [1] . Such a study does not usually begin with a specific 47 hypothesis, but seeks to develop and refine hypotheses through downstream 48 analysis of the data. A typical metabolomics analysis workflow usually involves 49 identifying a subset of compounds of interest in relation to the study objective, 50 which can be achieved in various ways not limited to statistical association testing, 51 multivariate statistical approaches, and machine learning (classification and 52 regression) [2] . Once compounds of interest are identified, the next step often 53 involves placing these in a biological context. Pathway analysis (PA) is perhaps the 54 most well-known computational approach for doing so, providing users with a list of 55 pathways considered enriched in the condition of interest (e.g. disease vs. healthy) 56

[3]. These pathways are curated using both manual and computational approaches 57 and deposited in databases, representing sets of biochemical reactions that 58 collectively perform a specific function [4] . 59

Conventional PA approaches widely used across omics data types (genomics, 60 transcriptomics, proteomics, and metabolomics, etc) commonly focus on a two-61 group analysis, seeking to identify significantly impacted pathways between the 62 study groups. These methods can be broadly classified into three main categories: 63 over-representation analysis (ORA) [5] , functional class scoring approaches such as 64 Although most ssPA methods are applicable to most omics datatypes, this will not 121 necessarily equate to their consistent performance across omics. Indeed, the most 122 well-known ssPA methods have all been developed for transcriptomic data analysis. 123

Other omics datatypes such as metabolomics differ greatly in composition and 124 statistical properties from transcriptomic data. The most obvious difference lies in 125 the number of metabolites versus the number of genes/transcripts profiled in 126 metabolomics and transcriptomics respectively, which has a direct effect on 127 pathway coverage (the proportion of entities in a given pathway that have been 128 assayed). Another key difference is the uncertainty in compound identification in 129 metabolomics which remains one of the field's greatest challenges [21] , an issue that 130 is far less prominent in transcriptomics and proteomics. Despite the potential of 131 ssPA methods for metabolomics, to date there have been no studies investigating the 132 efficacy of these methods when applied to metabolite datasets. The purpose of the 133 present research, therefore, is to perform a comprehensive benchmark of ssPA 134 methods applied to both real (experimental) and semi-synthetic metabolomics 135 datasets. We begin by evaluating the performance of four well-known ssPA methods, 136 namely SVD (PLAGE), ssGSEA, GSVA, and z-score using semi-synthetic data, and then 137 demonstrate using experimental data the value ssPA can add to a metabolomics 138 study. We also propose two novel methods for ssPA, ssClustPA and kPCA which are 139 available freely through the sspa package. This is the first study to benchmark ssPA 140 methods on metabolomics data, offering important insights into their suitability and 141 potential applications in metabolomics research. Both datasets are derived from untargeted mass spectrometry, see Table 1. Datasets  159 were post-processed in the same manner: missing value imputation using SVD, 160 probabilistic quotient normalisation, 2 transformation, and standardisation of 161 each variable ( = 0 and = 1). 162 2020using the COVID dataset. The use of a "permutation and spike" procedure 183 allows the original signal in the dataset to be erased and replaced with known 184 pathway signals, while preserving the underlying distributions (both joint and 185 marginal) and heterogeneity of the experimental data. This is advantageous 186 compared to generating fully synthetic data such as by random sampling from a 187 Gaussian distribution, as it preserves the complex biological relationships occurring 188 in omics data, which will influence method performance. A limitation of our 189 approach is that the underlying distribution of a particular dataset may differ from 190 that of other datasets. Despite this limitation, we believe this approach reflects more 191 accurately the level of complexity found in real data compared to fully-synthetic 192 simulation approaches. 

We used the OC as an alternative to the Jaccard Index (JI) as it is more sensitive to 259 overlapping compounds, i.e. the OC will return a value of 1 when the compounds in a 260 pathway are all present in a larger pathway, whereas the JI will only equal 1 if two 261 sets are identical. 262

In each of the simulations in this work, =3 randomly selected pathways = 264 

The kPCA method was used to demonstrate ssPA applied to the IBD metabolomics 298

Hierarchical clustering 300 kPCA pathway scores were standardised prior to clustering ( = 0 and = 1). 301

Hierarchical clustering was performed using the scipy cluster.hierarchy function 302

with Euclidean distance and Ward linkage parameters. The maxclust parameter was 303 set to 2 in order to cut the tree at a depth of 2 branches. The adjusted Rand index 304 was calculated using the metrics.adjusted_rand_score function, with the original 305 and predicted cluster sample labels as input. 306

Pathway score correlation network 307 kPCA pathway scores derived from the IBD dataset were ranked by t-test p-values 308 (testing for differences between IBD and non-IBD groups) and the top 50 pathways 309 were used to produce a hierarchical clustering as detailed above. Pathway IDs from 310 the resulting clusters were extracted and used to build the network. A Spearman 311 rank correlation matrix was produced from the pathway scores. networkx was used 312 to create a pathway-pathway network, with nodes representing pathways and edges 313 representing correlation between the pathway scores. Cytoscape was used to 314 visualise the network using an edge-weighted spring embedded layout. 315

The COVID pathway correlation network was created in the same way as the IBD 316 network, using the top 30 pathways (ranked by t-test p-values) for visual clarity. 317

Each node is coloured by the average pathway score of samples in each COVID WHO 318 severity level (0, 1-2, 3-4, 5-7). 319 320

Performance evaluation of ssPA methods 322 We first carry out a comprehensive benchmarking of ssPA methods applied to semi-323 synthetic metabolomics datasets generated based on the Su et al. COVID dataset 324

[22], see Methods. All pathways used throughout this work were obtained from the 325 Reactome pathway database [25] . Where applicable, we also compare ssPA results 326 to those obtainable using conventional PA methods ORA and GSEA. 327

Outline of simulation procedure 328

In order to calculate various performance metrics (i.e. precision and recall), it is 329 essential to know the identity of truly perturbed "enriched" pathways. Here we use 330 the terms "positively enriched" or "negatively enriched" to refer to pathways that 331 are significantly perturbed with respect to the control group, depending on the 332 directionality of the effect. In experimental datasets it remains challenging to 333 distinguish between true and false positive enriched pathways, so instead we use 334 semi-synthetic data to accomplish this task. As detailed in the methods, we remove The importance of pathway overlap in method evaluation 350

Due to the nature of biological pathways and how metabolic networks are connected 351 as a whole, defining precise pathway boundaries remains a challenge in pathway 352 curation. It is therefore expected that all pathway databases will contain some 353 degree of redundancy, meaning that not all molecules will be unique to a single 354 pathway. If a pathway is significantly enriched, it is likely that other pathways that 355 contain overlapping molecules with will also be considered enriched to varying 356 degrees. When performing benchmarking on redundant pathway sets, one must 357 therefore decide the level of pathway overlap that constitutes a true positive 358 pathway. 359

A simple example of the effect of pathway overlap is demonstrated in Fig 2. Here we 360 performed a simulation in which a single randomly selected pathway "R-HSA-361 1483206" (Glycerophospholipid biosynthesis) was enriched at effect size = 1. 362

Using the pathway scores derived from each ssPA method, a series of independent 363 two-sided t-tests were performed for each of the 255 Reactome pathways, testing 364 for significant differences in mean pathway scores between the two study groups. 365

The resulting pathway p-values are compared to the overlap coefficient (OC) of each 366 pathway with pathway R-HSA-1483206 in Fig. 2 . We can observe that regardless of 367 the ssPA method, there is a clear correlation between pathway overlap and p-value, 368 with pathways with lower overlap tending to have lower p-values. Importantly, if an 369 arbitrary p-value threshold e.g. p ≤ 0.05 was used to select significant pathways in 370 this manner, R-HSA-1483206 and a number of additional pathways would be 371 considered enriched. It is important to note this effect is not only observed with 372 ssPA methods, but also in conventional methods such as GSEA (Fig. 2) . 373 374 Fig 2: The relationship between pathway overlap and observations can be made in terms of AUC at an overlap threshold of ≥ 0.5 (Fig. 4b) . 427

The GSEA-based methods and z-score yield the highest AUC at lower effect sizes 428 As expected the performance of all methods improves as the signal strength 476 increases (Fig. 5) , aside from a small drop in precision which is caused by the 477 increase in signal strength rendering overlapping pathways more significant, as 478 highlighted in the previous simulation (Fig. 4) . In terms of recall, all ssPA methods 479 perform very similarly across signal strength sizes, and clearly outperform the 480 conventional PA methods ORA and GSEA. In contrast, the conventional methods 481 slightly outperform the rest of the ssPA methods in terms of precision, of which the 482 dimensionality-reduction based methods (SVD, ssClustPA, and kPCA) have higher 483 precision than GSEA/z-score-based methods. Overall, when taking into account 484 varying levels of signal strength, and that not all molecules in an enriched pathway 485 are likely to be significantly differentially abundant, clustering/DR-based methods 486 appear to offer the best overall performance in terms of ssPA, particularly at 487 moderate to high effect sizes (FC ≈≥ 1.5). 488 ssPA method ability to rank enriched pathways highly 489

The ability of the ssPA methods to rank enriched pathways highly was investigated, 490 again using the semi-synthetic COVID dataSu et al., 2020. Briefly, t-tests were 491 performed on the ssPA scores for each pathway (testing for a difference between 492 mean scores in disease and control groups) and the resulting p-values were used to 493 rank them in ascending order. The full set of 255 Reactome pathways was used. In 494 order to account for the fact that ORA generally tests fewer pathways than the other 495 methods (as it only calculates p-values for pathways with at least one differentially 496 abundant metabolite), the ranks were normalised by the total number of pathways 497 tested using each method. 498

In concordance with the performance metrics calculated in the previous section, at 499 lower effect sizes, the GSEA/z-score-based methods rank the truly enriched 500 pathways the highest (Fig. S3) . At higher effect sizes (0.8-1.0), there is very little 501 difference in the rankings of the enriched pathways by all ssPA methods, with all 502 methods being able to rank the 3 enriched pathways within the top 10% of 503 pathways. 504

Each ssPA method was run 10 times on a laptop with standard hardware and 16GB 506 of RAM using the Su et al., 2020COVID dataset, which contained 263 samples (rows) 507 and 335 compounds (columns), as well as Reactome pathways with sufficient 508 coverage in the dataset ( =255). In terms of runtime, the fastest method was the z-509 score, followed by SVD (Table S2) . 510

The remainder of this paper focuses on the application and interpretation of ssPA in 513 typical metabolomics data, using real experimental datasets. In order to simplify our 514 work, we demonstrated the use of a single method, kPCA, to showcase one of our 515 newly proposed methods, although the following application is generalisable to any 516 ssPA method. 517

In order to demonstrate some of the potential use cases of ssPA methods applied to 518 metabolomics data, we selected a different dataset to that used in the benchmarking 519 portion of this work and made use of ssPA to help detect and interpret complex 520 biological patterns within the data. The untargeted metabolomics data used in this 521 case study was derived from a multi-omics study of inflammatory bowel disease To obtain an exploratory perspective on the strength of the biological signals in the 527 dataset, PCA was used to visualise the data at both the metabolite and pathway level. 528 We transformed the metabolite-level data to pathway scores using the kPCA method 529 described earlier and compared the PCA results obtained. No strong separation 530 between the sample classes was observed using either approach, with most samples 531 amalgamated together in a central cluster (Fig. S4) . This is consistent with findings 532 from the original work, in which intra-individual variation in the IBD metabolome 533 was greater than inter-individual variation [ In order to more rigorously quantify the clustering performance achieved using 546 metabolites (only those present in pathways) vs. pathway scores, we ranked each of 547 the metabolites/pathways using BH-FDR corrected t-test q-values (testing for 548 differences between the IBD and non-IBD groups) and performed clustering after 549 progressively adding each entity significant at q ≤ 0.05 (Fig. 6) . Hierarchical 550 clustering was used to partition the samples into groups based on the two main 551 branches of the tree, which were compared to the original sample labels (IBD or 552 non-IBD) using the Adjusted Rand Index (ARI). Note that negative ARI values can be 553 obtained if the RI is less than expected by chance. This heuristic method suggested 554 that for this particular dataset, using pathway scores for clustering generally 555 achieves higher ARI across a range of different cut-off thresholds, as well as 556 improved robustness to the threshold used for clustering, than by using metabolites 557 alone. Consequently, we made use of the clustering applied to the top 50 sets of 558 pathway scores to identify clusters of pathways that could discriminate between the 559 IBD sample classes. Two distinct pathway clusters were evident (Fig. S5) , which we 560 visualised using Cytoscape in Fig 7.  561 The networks shown in Fig. 7 represent two distinct groups of pathways that 562 discriminate between IBD and non-IBD samples. An edge-weighted spring-563 embedded layout was applied to the network to visually group nodes by pathway 564 score Spearman correlation. The network nodes are coloured by the average 565 pathway score across the samples in each subtype (from top to bottom: non-IBD, CD, 566 UC). Using the kPCA approach (or clustering/DR-based approaches in general), it is 567 not possible to make a direct link between the sign of the pathway scores obtained 568 and the direction of the pathway enrichment. However, GSEA-based ssPA 569 approaches can be used to determine this, if desired. GSVA was used to determine 570 that cluster 1 of Fig. 7 represents pathways whose metabolites are upregulated in 571 IBD relative to the non-IBD group, whereas cluster 2 represents pathways with 572 metabolites depleted in IBD relative to the non-IBD group. 573 IBD encompasses a group of diseases broadly characterised by chronic inflammation 574 of the gut, and is widely attributed to a complex interplay of immune dysregulation, 575 dysbiosis of the gut microbiome, and genetic and environmental factors. A sub-576 cluster of immune-related pathways can be seen in cluster 1 (Fig. 7a) , highlighting 577 the role of phospholipids and Fc-gamma receptors in phagocytosis, which is 578 concordant with findings in current literature [26, 27] . Changes in phospholipid 579 metabolism are strongly implicated in IBD pathology, particularly in degradation of 580 the intestinal epithelial mucus layer [27] . Another pathway associated with 581 maintaining the integrity of the gut mucosal barrier highlighted in this cluster is 582 'Metabolism of polyamines' (Fig. 7b) , which corroborates the work of Weiss et al., 583 2004 [28] , who found increased levels of the polyamine spermidine alongside 584 decreased levels of spermine in IBD patients. One major benefit of ssPA is that it 585 enables comparison of pathway scores across multiple study groups. Using the 586 'Metabolism of polyamines' pathway as an example, we note that enrichment of the 587 pathway is greater in CD patients than it is in UC patients, relative to non-IBD 588 patients. A large sub-cluster of differentially active pathways relates to bile acid and 589 salt metabolism (Fig. 7c) In the second cluster, which consists of pathways whose metabolites are depleted in 597 IBD, a prominent sub-cluster containing pathways related to platelet homeostasis, 598 VEGF, and nitric oxide (NO) signalling is visible (Fig. 7e) . It is widely recognised that 599 platelet abnormalities are associated with IBD, alongside complications such as 600 microvascular thrombosis and thromboembolism [33] . The reduction in NO 601 signalling is consistent with findings of reduced NO-mediated vasodilation found in 602 IBD patients [34] , which could further contribute to thrombosis. This cluster of 603 pathways focused around VEGF signalling is one example that was not detected as 604 significantly enriched using ORA, but was detected amongst the top pathways using 605 ssPA (see Table S3 for ORA results). 606

Another large sub-cluster within cluster 2 focuses on DNA repair processes, 607 including base-excision repair (Fig. 7f) . This subcluster can be linked to another 608 significant pathway, 'ROS and RNS production in phagocytes' (Fig. 7g) , as reactive 609 oxygen species (ROS) contribute to DNA damage, which in turn induce DNA repair 610 mechanisms [35, 36] . The negative enrichment of these pathways may allude to 611 potential defects or reduction in DNA repair processes in IBD. 612

We also trained a random forest (RF) classifier on the IBD dataset, which based on 613 5-fold repeated stratified cross-validation achieved comparable AUC using kPCA 614 scores ( = 0.861, = 0.042) as did the classifier trained on the pathway-annotated 615 metabolites ( = 0.865, = 0.040). Pathway importances were calculated by 616 permuting each of the features individually, and ranked by the mean decrease in 617 AUC. Many of the top 50 pathways ranked by the RF classifier are shared with those 618 in the networks in Fig. 7 (see Table S4 ). 619

Using the same approach, a pathway-based correlation network was created using 620 the Su et al., 2020dataset (Fig. S6) . Using semi-synthetic metabolomics data, our benchmarking procedure evaluated 653 several properties of ssPA methods: recall, precision, AUC, and the ability to rank 654 enriched pathways highly. By varying simulation parameters such as effect size and 655 signal strength, we were able to ascertain how the methods performed under these 656 more realistic scenarios. Applied to transcriptomics data, GSVA is often a top 657 performer, particularly in gene-set recall [15, 19] . This finding is consistent with our 658 results, where GSVA was found to have higher recall than all other ssPA methods 659 across lower effect sizes, and at higher effect sizes had similar recall to ssGSEA. 660 GSEA-based methods may provide more power at lower effect sizes as they calculate 661 scores as a function of the compounds inside and outside of the pathway, testing a 662 competitive null hypothesis, whereas all other methods benchmarked (besides z-663 score) calculate scores based only on the compounds within a pathway itself. When 664 effect sizes become larger however, the recall of GSVA was found to be very similar 665 to that of ssGSEA and z-score. In contrast, when identifying correctly the enriched 666 pathways (precision), GSVA was one of the lowest performing methods, as opposed 667 to clustering and DR based methods ssClustPA, kPCA and SVD. In general therefore, 668 it can be inferred that GSEA/z-score-based methods offer higher recall (most 669 evident at lower effect sizes), whereas clustering/DR-based methods offer 670 improvements in precision, particularly at higher effect sizes, for metabolomics data. 671

In general we suggest the use of clustering/DR-based methods for datasets with 672 moderate-high effect sizes, and GSVA for datasets with lower effect sizes. 673

We offer two novel methods for ssPA: ssClustPA and kPCA, which can theoretically 674 be applied to any omics datatype. Leveraging fundamental machine learning 675 concepts of clustering and kernels respectively, both ssClustPA and kPCA have been 676 designed to make use of these unsupervised approaches to discriminate between 677 samples at the pathway level. ssClustPA is particularly advantageous when there is 678 clear structure to the underlying data, exploiting this to provide more precise 679 pathway scores. The RBF kernel used in the kPCA method allows complex non-680 linear structure within the data to be modelled and projected into a subspace where 681 datapoints become more linearly separable, and hence more likely to provide 682 precise pathway scores, which would otherwise not be feasible using linear 683 separation methods such as PCA or SVD. Applied to metabolomics data, these 684 methods have been shown to offer advances in precision compared to established 685 ssPA methods. Using metabolomics data from IBD samples, Click or tap here to enter 686 text.we employed kPCA to generate pathway scores, and created an IBD subtype-687 specific pathway network using this data. 688

Although the objective of this work was not to ascertain whether metabolite or 689 pathway level data yields better performance in downstream analyses, a key 690 question we were able to partially address was whether pathway-level data exhibits 691 greater predictive robustness than its metabolite-level counterpart [18] . Using the 692 IBD dataset, improved clustering performance was observed when using kPCA 693 pathway scores as opposed to individual metabolites. Not only was the maximum 694 ARI achievable higher using the pathway scores, but the range of ARI scores 695 obtained using a variety of different thresholds used to select which entities to 696 include in the clustering was consistently higher using pathway scores than 697 metabolites. This observation supports the hypothesis that in some cases pathway 698 scores can provide improved robustness to noise, one example of which is the 699 number of pathways used as features in downstream analyses. 700

We have undertaken the first comprehensive benchmark into ssPA methods for 701 metabolomics data. The insights gained from this study may provide guidance to 702 practitioners in the field for selecting an appropriate ssPA method, as well as 703 highlighting the broad range of applications for downstream analyses using pathway 704 

Metabolomics: beyond biomarkers and 721 towards mechanisms

Statistical analysis in metabolic phenotyping

Identifying significantly impacted 727 pathways: A comprehensive review and assessment

Metabolic pathway databases 730 and model repositories

Systematic 733 determination of genetic network architecture

Gene set enrichment analysis: A knowledge-based approach for 737 interpreting genome-wide expression profiles

A critical comparison of topology-based 740 pathway analysis methods

Ten years of pathway analysis: Current 743 approaches and outstanding challenges

Evaluation and comparison of bioinformatic tools for the 748 enrichment analysis of metabolomics data

751 Pathway analysis in metabolomics: Recommendations for the use of over-752 representation analysis

Benchmarking 758 algorithms for pathway activity transformation of single-cell RNA-seq data

Pathway level analysis of gene expression using 762 singular value decomposition

Systematic 765 RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

Gene set variation analysis for 768 microarray and RNA-Seq data

Inferring pathway activity toward 771 precise disease classification

Predict drug 774 sensitivity of cancer cells with pathway activity inference

Predictive modelling using pathway 777 scores: Robustness and significance of pathway collections

Single sample 780 scoring of molecular phenotypes

MOGSA: 783 Integrative single sample gene-set analysis of multiple omics data. Molecular 784 and Cellular Proteomics

Challenges, progress and 787 promises of metabolite annotation for LC-MS-based metabolomics. Current 788 Opinion in Biotechnology

Multi-Omics Resolves a 791 Sharp Disease-State Shift between Mild and Moderate COVID-19

Multi-omics of the gut microbial ecosystem in inflammatory bowel 795 diseases

Kernel principal component analysis. Lecture 797 Notes in Computer Science (including subseries Lecture Notes in Artificial 798 Intelligence and Lecture Notes in Bioinformatics)

The 801 reactome pathway knowledgebase

IgG and Fcγ receptors in intestinal immunity 804 and inflammation

Fat of the 807 Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases

Intracellular polyamine levels of intestinal epithelial cells in inflammatory 811 bowel disease

Review: microbial transformations of human bile acids

BioMed Central Ltd

Role of lipids in the metabolism and activation of 817 immune cells

Lipidomic 820 Profiling in Inflammatory Bowel Disease: Comparison Between Ulcerative 821 Colitis and Crohn's Disease

Fostering Inflammatory Bowel Disease

Thrombosis in 827 inflammatory bowel diseases: What's the link?

Acquired microvascular 830 dysfunction in inflammatory bowel disease: Loss of nitric oxide

ROS in gastrointestinal inflammation: Rescue Or 834 Sabotage?

Oxidative Stress and DNA Damage: 837 Implications in Inflammatory Bowel Disease

Topology-Based Single Sample 840 Pathway Analysis Method

Evaluation of Pathway 843 Activation for a Single Sample Toward Inflammatory Bowel Disease 844 Classification

ssGSEA score-based Ras 847 dependency indexes derived from gene expression data reveal potential Ras 848 addiction mechanisms with possible clinical implications

Kyoto Encyclopedia of Genes and Genomes. Nucleic 854 Acids Research

The 857 MetaCyc database of metabolic pathways and enzymes and the BioCyc 858 collection of Pathway/Genome Databases

Fast gene set enrichment analysis. 861 bioRxiv

The authors gratefully acknowledge Fabien Jourdan, Nathalie Poupin, Clément 875 Frainay, and Juliette Cooke for insightful and stimulating discussions regarding this 876 work and for critical reading of the manuscript. 877